Cephalothin-induced tachycardia following aortic valve replacement.
D001024:Aortic Valve Stenosis / Q000601:surgery*; D001663:Bilirubin / Q000097:blood; D001831:Body Temperature; D002496:Central Venous Pressure; D002512:Cephalothin / Q000009:adverse effects*; D006242:Haptoglobins; D006339:Heart Rate; D006350:Heart Valve Prosthesis; D006454:Hemoglobins; D006461:Hemolysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012129:Respiratory Function Tests; D013530:Surgical Wound Infection / Q000517:prevention & control*; D013610:Tachycardia / Q000139:chemically induced*; D013927:Thrombosis / Q000517:prevention & control
D006242:Haptoglobins; D006454:Hemoglobins; D002512:Cephalothin; D001663:Bilirubin